Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma.
Lynette M
LM
Sholl
Aleodor
A
Andea
Julia A
JA
Bridge
Liang
L
Cheng
Michael A
MA
Davies
Mani
M
Ehteshami
Tara C
TC
Gangadhar
Suzanne
S
Kamel-Reid
Alexander
A
Lazar
Kirtee
K
Raparia
Alan
A
Siroy
From the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl);|the Department of Pathology, University of Michigan Hospitals, Ann Arbor (Dr Andea);|the Department of Pathology, University of Nebraska Medical Center, Omaha (Dr Bridge);|the Department of Pathology, Indiana University, Indianapolis (Dr Cheng);|the Departments of Melanoma Medical Oncology and Systems Biology (Dr Davies).|Pathology (Drs Lazar and Siroy), and Translational Molecular Pathology (Dr Lazar).|The University of Texas MD Anderson Cancer Center, Houston, Texas; Newport Coast Pathology Inc, Newport Beach, California (Dr Ehteshami);|the Department of Medicine and the Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia (Dr Gangadhar);|the Department of Pathology, The University Health Network/Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Kamel-Reid);|the Department of Pathology, Northwestern University, Chicago, Illinois (Dr Raparia); and Cancer Registry Consultant, Sioux Falls, South Dakota (Ms Watson).|and Cancer Registry Consultant, Sioux Falls, South Dakota (Ms Watson).
Kimberly L
KL
Watson
D014408:Biomarkers, Tumor / Q000032:analysis* / Q000235:genetics; D004252:DNA Mutational Analysis; D006801:Humans; D008545:Melanoma / Q000175:diagnosis* / Q000235:genetics; D013048:Specimen Handling
D014408:Biomarkers, Tumor